Contact A Counsellor

counsellor button


teen suicide icon


panic anxiety icon

panic anxiety icon

#MindfulMondays with Miss SA

teen suicide icon


Research on Depression in the Workplace.

For more information please click here



email subscribers list

To subscribe to SADAG's newsletter, click here

To view previous newsletters - click here


Mental Health Matters Journal for Psychiatrists & GP's

MHM Volume 8 Issue1

Click here for more info


journalists crew making newspaper

If you are a journalist writing a story contact Kayla on 011 234 4837  media@anxiety.org.za


MySchool Facebook banner Nov

It’s the small things that make a BIG difference. Sign up for the “My School | My Village | My Planet” Card and start making a difference to Mental Health in South Africa today.

Click Here


cope with cancer book

Literacy is a luxury that many of us take for granted. That is why SADAG created SPEAKING BOOKS and revolutionized the way healthcare information is delivered to low literacy communities.

The customizable 16-page book, read by local celebrity audio recordings, ensures that vital health and social messages can be seen, heard, read and understood by everyone across the world.

We started with books on Teen Suicide prevention , HIV, AIDS and Depression, Understanding Mental Health and have developed over 100+ titles, such as TB, Malaria, Polio, Vaccines for over 45 countries.

suicide speaking book

Children and adolescents with disabling anxiety are most likely to recover when treated with a combination of talk therapy and an antidepressant medicine, according to the largest study to date of anxiety disorders in this age group.

The government-financed study, which tracked nearly 500 patients, found that 8 in 10 children who received the combined therapy improved significantly, compared with less than 6 in 10 who had either the drug or the talk therapy (known as cognitive behavior therapy) on its own.

The study, released online Thursday by The New England Journal of Medicine, clarifies the treatment picture for these young patients and should increase interest in combined therapy, experts said. Up to half of children and adolescents struggling with chronic anxiety do not seem to improve much in treatment, psychiatrists estimate.

The researchers reported no increase in serious side effects from Zoloft, the antidepressant used in the study; the drug belongs to a class of medications that has been associated with a small risk of suicidal thinking and behavior in young patients.

“It’s surprising that they found such a dramatic difference between combined treatment and the others,” said Dr. Sanjiv Kumra, director of the child and adolescent psychiatry program at the University of Minnesota, who was not involved in the research. “I think this should be reassuring for parents interested in finding good treatment for a child, and it should send a message to third-party payers.”

In the new report, from a continuing study financed by the National Institute of Mental Health, researchers recruited children ages 7 to 17 whose anxiety over separation from parents, social situations or other things was causing problems.

The doctors split the youngsters into four groups: one receiving Zoloft; another engaging in cognitive therapy; a third receiving both; and a group receiving dummy pills and monitoring by the psychiatrist. In the talk treatment, therapists teach children to identify the thoughts that amplify their worries, and then defuse or moderate them; parents help reinforce the lessons.

After 12 weeks, 80 percent of children receiving the combined therapy had either shaken their anxiety or improved very much. Similar improvements were found in about 60 percent of those getting talk therapy alone; 55 percent of those receiving Zoloft alone; and less than a quarter of those taking dummy pills.

“All of the treatment options employed may be recommended, taking into consideration the family’s treatment preferences” as well as cost and availability, concluded the study authors, led by Dr. John T. Walkup of Johns Hopkins and Dr. Philip C. Kendall of Temple University.


Our Sponsors

Our Partners